v3.26.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Sale of product $ 2,378,924 $ 3,238,900
Cost of product 1,227,976 1,206,863
Gross profit 1,150,948 2,032,037
Operating costs and expenses:    
Salaries and contract labor 1,297,617 1,119,326
General, administrative, and consulting 1,014,235 871,024
Research and development 149,128 106,703
Total operating expenses 2,460,980 2,097,053
Net operating loss (1,310,032) (65,016)
Other income (expense):    
Other income 32,475 14,349
Interest income 14,340 21,824
Interest expense (84,869) (83,851)
Total other expense (38,054) (47,678)
Net loss $ (1,348,086) $ (112,694)
Net loss per common share - basic: (in dollars per share) $ 0 $ 0
Net loss per common share - diluted: (in dollars per share) $ 0 $ 0
Weighted average common shares outstanding - basic (in shares) 528,459,473 524,082,026
Weighted average common shares outstanding - diluted (in shares) 528,459,473 524,082,026